A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19 https://www.medrxiv.org/content/10.1101/2023.03.25.23287712
A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19 https://www.medrxiv.org/content/10.1101/2023.03.25.23287712